Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaMelphalanTransplantation, HomologousRemission InductionTransplantation ConditioningCombined Modality TherapyTreatment OutcomeSalvage TherapyStem CellsDisease-Free SurvivalEtoposideCyclophosphamideHodgkin DiseaseRecurrenceCytarabineLymphoma, Non-HodgkinMyeloablative AgonistsCarmustineSurvival RateBone Marrow TransplantationGraft vs Host DiseaseHematopoietic Stem Cell MobilizationVincristineThiotepaBone Marrow PurgingSurvival AnalysisHematologic NeoplasmsLymphoma, Mantle-CellWhole-Body IrradiationRetrospective StudiesDoxorubicinAmyloidosisPrognosisHematopoietic Stem CellsBusulfanDexamethasoneBoronic AcidsPyrazinesFollow-Up StudiesAntibodies, Monoclonal, Murine-DerivedGraft SurvivalLymphoma, FollicularAntineoplastic Agents, AlkylatingAntigens, CD34Lymphoma, T-Cell, PeripheralAutograftsThalidomideLiver TransplantationAntineoplastic AgentsIfosfamidePrednisoneTime FactorsInduction ChemotherapyGranulocyte Colony-Stimulating FactorMesenchymal Stem Cell TransplantationLeukapheresisLymphomaPodophyllotoxinNeoplasm, ResidualLeukemia, Myeloid, AcuteLymphoma, Large B-Cell, DiffuseMaintenance ChemotherapyTransplantation ChimeraTissue DonorsCord Blood Stem Cell TransplantationCell TransplantationIdarubicinLymphoma, B-CellMyelodysplastic SyndromesKidney TransplantationEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsMitoxantroneNeoplasms, Second PrimaryLeukemia, Plasma CellProspective StudiesCisplatinInfusions, SpinalImmunosuppressive AgentsCarboplatinBlood Component RemovalAdult Stem CellsLeukemia, MyeloidNeoplasm Recurrence, LocalDrug Administration ScheduleAntibodies, MonoclonalChemotherapy, AdjuvantHistocompatibility TestingFeasibility StudiesFatal OutcomeLeukemiaBone MarrowCell DifferentiationLife TablesAcute Disease